Say hello to our latest cohort of InSPIRE students 👋 The undergraduate students from leading institutions in China, India, Japan, Korea, and Singapore are spending 10 weeks in labs learning from scientists across Melbourne’s Parkville biomedical precinct. Showcasing the excellence of Australian medical research, the InSPIRE program provides the opportunity to further strengthen collaborative research ties with top institutions across Asia. A big thank you to our wonderful InSPIRE program supporters including Australian China Education Foundation (ACEF), Bodhi Foundation, China Construction Bank (CCB), The National Foundation for Australia-China Relations (NFACR) 澳中基金会, Skysea, and City of Melbourne. Find out more about the program 👇 Peter MacCallum Cancer Centre Bio21 Institute The Peter Doherty Institute for Infection and Immunity Olivia Newton-John Cancer Research Institute The Florey
WEHI (Walter and Eliza Hall Institute of Medical Research)’s Post
More Relevant Posts
-
Today we share a major milestone in our commitment to advancing vision research. The Foundation Fighting Blindness, in collaboration with Nixon Visions Foundation, has announced the recipients of the inaugural grants in the PRPH2 and Associated Retinal Diseases (PARD) Program. After an extensive international call for proposals, nearly $1 million has been awarded to two outstanding researchers: 🔬 Dr. Andrew Goldberg of Oakland University, for his project on "Natural History and AAV-Mediated Interventions for Dominant Negative and Haploinsufficient Mouse Models of PRPH2-Associated Disease." 🔬 Dr. Yoshikazu Imanishi of Indiana University, for his project on "Elucidating Pathophysiological Mechanisms and Advancing High-Throughput Drug Discovery in PRPH2-Related Retinal Dystrophies." These grants represent a significant investment in cutting-edge research aimed at understanding and treating PRPH2-related retinal diseases. We are excited about the potential breakthroughs these projects could bring, which promise to restore vision and improve the quality of life for individuals affected by these conditions. "We are proud to provide financial support to these exceptional researchers," said Brandon Nixon, CEO of Nixon Visions Foundation. "We look forward to the important discoveries these initial grants will yield as part of our multi-year PRPH2 research funding initiative." Watch the video above featuring Jason Menzo, CEO of Foundation Fighting Blindness, to learn more about this exciting development and stay tuned for updates on this pivotal moment in inherited retinal disease research. Learn more: https://lnkd.in/gSexThjt #VisionScience #RetinalResearch #PRPH2 #NixonVisionsFoundation #FightBlindness #InnovationInResearch #HopeForSight
-
Just one reason to publish your research in #immunology with us: 🔎 We offer a fast and fair review process – the average time for submission to acceptance is under 100 days, and all submissions are evaluated in depth by our international and diverse editorial board in subspecialities spanning the molecular #lifesciences. Other benefits include: 🔓 Option to submit #openaccess. 🌎 High visibility of published papers. ✅ Format-free submission. ♻️ All revenue is reinvested back into the scientific community. Follow the link in comments to learn more about our leading peer reviewed journal and browse recently published articles in #immunology, including: ‘A guide to germ-free and gnotobiotic mouse technology to study health and disease’ – authored by Maude Jans and Lars Vereecke. FEBS
-
-
A Pitt study published in the January issue of Oral Oncology utilized whole exome and bulk RNA sequencing to identify differences between cSCC arising in immunosuppressed and immunocompetent patients. They demonstrated an enrichment in microsatellite instability in the tumors from immunosuppressed patients and differences in oxidative phosphorylation and epithelial-mesenchymal transition, which may be targets for therapeutic intervention based on identification of mutations. #otolaryngology #headandneckcancer #genomics #immunosuppression #organtransplantation #cutaneoussquamouscellcarcinoma #tumors #mutations #immunocompetent #futuretreatments Genomic and transcriptomic analysis of cutaneous squamous cell carcinoma arising in immunocompetent and immunosuppressed patients - PubMed (nih.gov)
National Institutes of Health (NIH)
nih.gov
-
NEW ON-DEMAND COURSE NOW AVAILABLE - Advance your knowledge on MSCs for Autoimmune Diseases! Leveraging ISCT global network Leaders and Principal Investigators, including Katarina Le Blanc, MD, PhD, Mark Lowdell, PhD, Dominique Farge, MD, PhD, and Gary Gilkeson, MD, who have led significant studies in MSC research and clinical trials, The ISCT Institute of Training and Development has curated the Cell Therapies for Autoimmune Diseases: MSCs for Clinical Applications on-demand course. In this 8-hour case study-based ASCP accredited training course, learn from global leaders in the MSC field on the critical knowledge, methods, and considerations to apply when translating the use of MSC for autoimmune diseases. Learn more and register: https://buff.ly/4eSAOpJ
-
-
Deputy Lead Head Inflammasome Lab - Senior Research Fellow at UQ Institute for Molecular Bioscience
Younger me was terrified of submitting a paper to any journal - thoughts of rejection and failure were dominant; it felt like being back at school handing in an exam, and the teacher corrected it with a red pen - no feedback, no learning curve. Publishing is different; it is a communication channel with your peers, the Editor, and you to lift up your work. Keen to hear insights from Editors from #Cell #NatureMethods #Science and #BiochemicalSociety? Join us at the end of the month for our ACDS workshop on "From Pitch to Publication - Insights from Editors"
Coming up later this month: our biennial "From Pitch to Publication" Workshop! We're absolutely thrilled to be hosting four incredible speakers: Dr Michael Funk, Dr Cheri Sirois, Prof James Murphy and Dr Rita Strack 👏 Our fantastic panel are all Scientific Editors with invaluable insights from their careers at internationally-renowned Journals, including Nature Portfolio, Cell Press, Science Magazine, Biochemical Society, and more! Join us from 9 - 10.30 am AEST on Wednesday 29th May (via Zoom) to hear Dr Funk discuss strategies for opening communication with Editors; Dr Sirois share her how-to for crafting effective abstracts; Prof Murphy explore how early and mid-career researchers can get involved with peer-review (with tips & tricks!); and Dr Strack guide us on navigating appeals and rebuttals in the post-review process! See flyer for details, including QR code and Zoom link. Event is not restricted to ACDS members; all are welcome, so feel free to share the flyer and details with your friends and colleagues, and let us know in the comments if you're coming! This is not one to miss - we can't wait! 🤩 The ACDS is proudly supported by WEHI (Walter and Eliza Hall Institute of Medical Research) #earlycareerresearchers #midcareerresearchers #celldeath #PhDstudents #academicpublishing #peerreview La Trobe Institute for Molecular Science (LIMS) Hudson Institute of Medical Research Peter MacCallum Cancer Centre Baker Heart and Diabetes Institute The Peter Doherty Institute for Infection and Immunity
-
-
Do you want to know more about the gut barrier function? Next week (23rd of May) I will present a webinar about monitoring the barrier function of an in vitro gut mimic using impedance spectroscopy. I will talk about the requirements for a functional gut mimic, followed by a crash course impedance spectroscopy and TEER (TransEpithelial Electrical Resistance) measurements and I will end the webinar with real data about barrier manipulation. Register now for the webinar!
🔔 Upcoming Webinar: “Does all disease begin in the gut? Monitoring the barrier function of an in vitro gut mimic” 🔔 Join us on May 23rd for an insightful session presented by Eline Geervliet, Application Scientist at Locsense B.V.. The event will be hosted and accommodated by Brian Shapiro, Ph.D., Marketing Segment Manager at ATCC, and will feature data insights from Lena Sophie Koch, PhD candidate at the Applied Stem Cell Technologies (AST) group, University of Twente. 🌐 Webinar Details: Title: Does all disease begin in the gut? Monitoring the barrier function of an in vitro gut mimic Date: May 23rd, 2024 Time: 1 pm GMT 🚀 Reasons to attend: Explore groundbreaking research on gut health and its impact on disease. Gain insights into the barrier function of an in vitro gut mimic. Learn how sensor data can revolutionize our understanding of health and disease prevention. 🔗 Register Now: Don’t miss this opportunity to expand your knowledge and network with industry experts! See you there! 👋 https://lnkd.in/eFvvTTTf #Webinar #HealthResearch #GutHealth #InVitroStudy #DiseasePrevention #drugdevelopment
-
-
Check out our latest Customer Spotlight with Dr. Elaine Lim!
Excited to embark on scientific adventures with collaborators Ben Readhead, Rigel Chan, Fiachra Humphries and more. And super grateful to NIH AMP-AD, PolyBio Research Foundation for funding our work.
CUSTOMER SPOTLIGHT: Viral Infections & Neurodegenerative Disease with Dr. Elaine Lim
psomagen.com
-
🌍 Luxembourg's Parkinson’s Research Joins Global Effort We are thrilled to announce that the National Centre of Excellence in Research on Parkinson’s Disease (NCER-PD) has joined the landmark Parkinson’s Progression Markers Initiative (PPMI) by The Michael J. Fox Foundation for Parkinson's Research! 🧬 About PPMI: Launched in 2010, PPMI is the most ambitious study in Parkinson’s research, aiming to develop biomarkers for Parkinson’s disease risk, onset, and progression. 🏥 Our Role: #Luxembourg’s expertise in establishing diverse cohorts will be invaluable. We will recruit local participants, including those at risk, contributing to a deeper understanding of Parkinson’s disease. 👥 Participant Enrolment: Started in April, aiming to recruit at least 50 individuals by December 2026. 🔬 Expert Insight: Prof. Rejko Krüger emphasises the importance of understanding risk factors in predicting the onset and progression of Parkinson’s disease. 💬 Michael J. Fox Foundation: Dr. Mark Frasier highlights the transformative impact of community support in Parkinson’s research. Join us in celebrating this milestone in Parkinson’s research! The news was announced by the five partner organisations, the Luxembourg Institute of Health, the Centre Hospitalier de Luxembourg, the University’s Luxembourg Centre for Systems Biomedicine (LCSB) - University of Luxembourg, the LNS - Laboratoire national de santé and Les Hôpitaux Robert Schuman (HRS). #ParkinsonsDisease | University of Luxembourg
Luxembourg’s Parkinson’s disease research excellence goes global
https://www.uni.lu/en
